Departments & Organizations
LCME Institutional Self-Study Task Force: LCME Medical Students Subcommittee
Dr. Krystal is a leading expert in the areas of alcoholism, schizophrenia, and post-traumatic stress disorder. His work links psychopharmacology, neuroimaging, and molecular genetics to study the neurobiology and to develop novel treatments for these disorders.
He is a member of the Institute of Medicine of the National Academies. He also serves in a variety of advisory and review capacities for NIAAA, NIMH, Wellcome Trust, Brain and Behavior Research Foundation, and the Karolinska Institutet.
He previously served on the National Alcohol Abuse and Alcoholism Advisory Council (NIAAA), the Department of Defense Psychological Health Advisory Committee, the NIMH Board of Scientific Counselors (chair, 2005-2007), American College of Neuropsychopharmacology (president, 2012), and International College of Neuropsychopharmacology (president-elect).
Dr. Krystal also edits the journal, Biological Psychiatry (impact factor: 9.472).
Education & Training
|MD||Yale University (1984)|
|BA||University of Chicago, Behavioral Sciences (1980)|
|Residency||Yale University School of Medicine|
Honors & Recognition
Anna-Monika Prize in Depression ResearchAnna-Monika Foundation, Munich, Germany (2009)
Joel Elkes AwardAmerican College of Neuropsychopharmacology (2001)
Kempf Award for Contributions to Schizophrenia Research through Research and MentorshipAmerican Psychiatric Association (2005)
Stanley Dean Award for Schizophrenia ResearchAmerican College of Psychiatry (2010)
Jack Mendelson Award for Clinical ResearchNational Institute on Alcohol Abuse and Alcoholism (2010)
MemberInstitute of Medicine, U.S. National Academies of Science (2010)
Exemplary Psychiatrist AwardNational Alliance on Mental Illness (2011)
Paul Hoch Research AwardAmerican Psychopathological Association (2014)
President American College of Neuropsychopharmacology (2011 - 2012)
President-Elect International College of Neuropsychopharmacology (2014 - 2016)
Schizophrenia Treatment Taichung, Taiwan (2013 - 2014)
Consulting regarding novel treatments for schizophrenia and ketamine-related psychosis.
Neuroimaging studies of schizophrenia and related disorders Chengdu, China (2012 - 2014)
Neuroimaging studies of brain structure and function associated with psychosis
Rapid Acting Antidepressant Treatment Taipei, Taiwan (2012 - 2014)
Consulting to a study conducted evaluating the antidepressant effects of ketamine, led by Dr. Tung-Ping (Tom) Su.
Ketamine Psychosis Guangzhou, China (2010 - 2014)
Studying the phenomenology and genetics of ketamine psychosis in relation to schizophrenia
Clinical Archives Project Cherite Hospital Berlin, Germany (2006 - 2014)
The Department of Psychiatry at Cherite Hospital in Berlin has long been a home to ethical and compassionate treatment of patients. However, in the period leading up to World War II, its psychiatry leadership involved the hospital in the emerging eugenics movement. This work, contributed to the...